Dietary Fat, Lipoprotein and Lipopolysaccharide: Role in Insulin Resistance
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2015
At a glance
- Drugs Rifaximin (Primary)
- Indications Inflammation
- Focus Pharmacodynamics; Proof of concept
- 07 Jun 2017 Biomarkers information updated
- 26 May 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 29 Oct 2014 Planned initiation date changed from 1 Jun 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.